In vitro titration of tetanus antitoxin

In vitro methods are used as an alternative to the expensive and time-consuming official method in mice for the titration of tetanus antibodies. Numerous techniques have been developed and used for this purpose, but with mixed results. The difficulty is to get good correlation with in vivo units whatever the vaccinal status of the individual. Today, some of these serological techniques have been virtually abandoned in favor of others which are becoming widespread. RIA is still used, but only in laboratories which already have the necessary equipment and skill. It is gradually replaced by ELISA, a rather delicate technique which however has kept its promises and is amenable to further progress. Passive haemagglutination has been greatly improved by the use of turkey erythrocytes. With this modification, this technique becomes reliable and sensitive and is apparently able to give good results for a large number of sera in case of mass investigation as well as for a quick estimate of the protective level in an individual.     

破伤风抗毒素临床反应观察报告

作者对兰州生物制品研究所常规生产的3批破伤风抗毒素（TAT）进行了临床反应观察。结果表明,TAT皮内试验假阳性反应率平均为13．3％,阳性反应率为0．9％。450例患者注射后过敏反应发生率为0,年龄,性别因素与皮试阳性率及注射后反应无相关性。     

Biological properties of immunochemically pure tetanus antitoxin

Immunochemically pure tetanus antitoxin obtained from enzyme-treated horse serum is less reactogenic and anaphylactogenic and possesses higher therapeutic properties than antitoxin purified by nonspecific physico-chemical methods and containing ballast antigens. Due to its increased persistence in the recipient's body, the immunochemically pure antitoxin induces passive immunity in considerably lower doses than the preparations purified by the method "Diaferm-3".     

Neonatal tetanus despite protective serum antitoxin concentration

Using the ELISA technique to estimate serum antibodies against tetanus toxin, seven neonates with clinical tetanus were found to have antibody levels 4-13 times higher than the presumed minimum protective level of 0.01 IU/ml. All but one of their mothers had been vaccinated with tetanus toxoid in pregnancy. In two other neonates, whose mothers had received multiple booster doses of toxoid during pregnancy, the anti-toxin concentrations were 100- and 400-times the presumed protective level. Therefore the toxin dose may overwhelm the pre-existing anti-toxin level and produce disease. Furthermore, multiple booster injections of tetanus toxoid may not only enhance serum anti-toxin titres, but could also lead to an ineffective immune response.